Is whole blood or plasma more accurate for detecting Epstein-Barr virus?
Generally, in EB virus testing, the accuracy of whole blood versus plasma depends on the specific testing purpose and disease stage. Plasma is usually more accurate, but under certain circumstances, whole blood may be preferable. The detailed analysis is as follows:

When detecting EB virus nucleic acid, plasma is typically more accurate. The virus primarily resides within peripheral blood mononuclear cells. After centrifugation removes cellular components, plasma reduces interference from cellular impurities, allowing test reagents to more precisely capture viral nucleic acids. Especially during the acute phase of infection when viral load is high, plasma testing provides more stable results and clearly reflects the level of viral replication activity.
When detecting EB virus antibodies, whole blood has advantages. Antibodies are widely distributed in the serum component of whole blood. Whole blood samples are easier to process and provide sufficient targets directly for antibody testing. During the recovery phase or screening for past infections, whole blood testing can more conveniently and accurately identify positive antibody results, avoiding potential sample loss during plasma separation that might affect interpretation.
In clinical diagnosis, laboratories strictly follow standards to select the appropriate sample type; patients do not need to choose by themselves. If there are questions about test results, it is recommended to consult a physician or laboratory specialist regarding the impact of sample type.